Hans Dieplinger

8.6k total citations
132 papers, 6.0k citations indexed

About

Hans Dieplinger is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Hans Dieplinger has authored 132 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Surgery, 37 papers in Endocrinology, Diabetes and Metabolism and 36 papers in Molecular Biology. Recurrent topics in Hans Dieplinger's work include Lipoproteins and Cardiovascular Health (66 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (30 papers) and Cancer, Lipids, and Metabolism (26 papers). Hans Dieplinger is often cited by papers focused on Lipoproteins and Cardiovascular Health (66 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (30 papers) and Cancer, Lipids, and Metabolism (26 papers). Hans Dieplinger collaborates with scholars based in Austria, Germany and United States. Hans Dieplinger's co-authors include Florian Kronenberg, Gerd Utermann, Paul König, Gerhard M. Kostner, Benjamin Dieplinger, Evi Trenkwalder, Fritz Hoppichler, Karl Lhotta, Eric Boerwinkle and C. Sandholzer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Hans Dieplinger

129 papers receiving 5.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Dieplinger Austria 45 3.3k 1.8k 1.3k 1.1k 921 132 6.0k
Gilbert R. Thompson United Kingdom 43 4.1k 1.2× 2.2k 1.2× 876 0.7× 1.2k 1.1× 1.3k 1.4× 172 6.1k
Patricia G. Yancey United States 38 2.5k 0.8× 978 0.5× 2.4k 1.9× 772 0.7× 489 0.5× 70 5.7k
William J. Johnson United States 36 2.0k 0.6× 816 0.4× 2.1k 1.6× 489 0.4× 355 0.4× 86 5.3k
Armin Steinmetz Germany 34 3.1k 0.9× 2.6k 1.4× 1.6k 1.2× 1.1k 1.0× 858 0.9× 112 5.2k
Eleni Bairaktari Greece 36 1.4k 0.4× 1.1k 0.6× 946 0.7× 501 0.5× 517 0.6× 146 3.9k
Margarita de la Llera-Moya United States 29 3.7k 1.1× 2.3k 1.2× 1.8k 1.4× 1.1k 1.0× 772 0.8× 42 5.5k
Gerhard M. Kostner Austria 55 4.9k 1.5× 3.1k 1.7× 2.7k 2.1× 2.4k 2.2× 1.8k 1.9× 260 10.5k
Marlys L. Koschinsky Canada 53 6.1k 1.9× 1.9k 1.0× 1.5k 1.2× 2.4k 2.2× 2.5k 2.7× 190 9.4k
Liam R. Brunham Canada 41 3.5k 1.1× 1.4k 0.8× 2.0k 1.6× 945 0.9× 1.1k 1.2× 133 6.0k
G.M. Anantharamaiah United States 34 2.1k 0.6× 1.6k 0.9× 1.8k 1.4× 741 0.7× 531 0.6× 70 4.9k

Countries citing papers authored by Hans Dieplinger

Since Specialization
Citations

This map shows the geographic impact of Hans Dieplinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Dieplinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Dieplinger more than expected).

Fields of papers citing papers by Hans Dieplinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Dieplinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Dieplinger. The network helps show where Hans Dieplinger may publish in the future.

Co-authorship network of co-authors of Hans Dieplinger

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Dieplinger. A scholar is included among the top collaborators of Hans Dieplinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Dieplinger. Hans Dieplinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kollerits, Barbara, Fruzsina Kotsis, Markus P. Schneider, et al.. (2024). Association of Serum Afamin Concentrations With Kidney Failure in Patients With CKD: Findings From the German CKD Cohort Study. American Journal of Kidney Diseases. 85(4). 432–441.e1.
2.
3.
Köninger, Angela, Paweł Mach, Mirjam Frank, et al.. (2018). Afamin: an early predictor of preeclampsia. Archives of Gynecology and Obstetrics. 298(5). 1009–1016. 22 indexed citations
4.
Naschberger, Andreas, Andrew Orry, Stefan Lechner, et al.. (2017). Structural Evidence for a Role of the Multi-functional Human Glycoprotein Afamin in Wnt Transport. Structure. 25(12). 1907–1915.e5. 24 indexed citations
5.
Seeber, Beata, et al.. (2014). Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome. Reproductive Biology and Endocrinology. 12(1). 88–88. 37 indexed citations
6.
Buchner, Hannes, M Mörtl, Dietmar Schlembach, et al.. (2014). The vitamin E-binding protein afamin increases in maternal serum during pregnancy. Clinica Chimica Acta. 434. 41–47. 40 indexed citations
7.
Ikewaki, Katsunori, Evi Trenkwalder, Claudia Lamina, et al.. (2012). In vivo stable-isotope kinetic study suggests intracellular assembly of lipoprotein(a). Atherosclerosis. 225(2). 322–327. 49 indexed citations
8.
9.
Finkenstedt, Armin, Andreas Widschwendter, Carole Brasse‐Lagnel, et al.. (2012). Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy. Blood Cells Molecules and Diseases. 48(4). 233–237. 35 indexed citations
10.
Schwaiger, Johannes P., Claudia Lamina, Ulrich Neyer, et al.. (2006). Carotid Plaques and Their Predictive Value for Cardiovascular Disease and All-Cause Mortality in Hemodialysis Patients Considering Renal Transplantation: A Decade Follow-Up. American Journal of Kidney Diseases. 47(5). 888–897. 28 indexed citations
11.
Huang, Honglei, Taras Stasyk, Sandra Morandell, et al.. (2006). Biomarker discovery in breast cancer serum using 2‐D differential gel electrophoresis/ MALDI‐TOF/TOF and data validation by routine clinical assays. Electrophoresis. 27(8). 1641–1650. 111 indexed citations
12.
Salvenmoser, Willi, Arno Lingenhel, Christian Rudolph, et al.. (2005). Immunohistochemical localization of apolipoprotein A-IV in human kidney tissue. Kidney International. 68(3). 1130–1136. 16 indexed citations
13.
Eckardstein, Arnold von, David Crook, Jolanda M. H. Elbers, et al.. (2003). Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux. Clinical Endocrinology. 58(1). 49–58. 30 indexed citations
14.
Kronenberg, Florian, Karl Lhotta, Paul König, et al.. (2003). Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation. European Journal of Human Genetics. 11(9). 693–699. 15 indexed citations
15.
Kronenberg, Florian, Markus Stühlinger, Evi Trenkwalder, et al.. (2000). Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease. Journal of the American College of Cardiology. 36(3). 751–757. 85 indexed citations
16.
Kronenberg, Florian, Evi Trenkwalder, Martina F. Kronenberg, et al.. (1998). Influence of hematocrit on the measurement of lipoproteins demonstrated by the example of lipoprotein(a). Kidney International. 54(4). 1385–1389. 30 indexed citations
17.
Trenkwalder, Evi, et al.. (1997). Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease: Rapid Communication. Kidney International. 52(6). 1685–1692. 28 indexed citations
18.
Dieplinger, Hans, et al.. (1997). Biogenesis of lipoprotein(a) in human and animal hepatocytes. Electrophoresis. 18(14). 2677–2681. 6 indexed citations
19.
Lackner, Karl J., Hans Dieplinger, Grażyna Nowicka, & Gerd Schmitz. (1993). High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene.. Journal of Clinical Investigation. 92(5). 2262–2273. 39 indexed citations
20.
Menzel, Hans-J�rgen, et al.. (1990). Frequency and effect of human apolipoprotein A-IV polymorphism on lipid and lipoprotein levels in an Icelandic population. Human Genetics. 84(4). 344–6. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gilbert R. Thompson Breakdown of academic impact, for papers by Patricia G. Yancey Breakdown of academic impact, for papers by William J. Johnson Breakdown of academic impact, for papers by Armin Steinmetz Breakdown of academic impact, for papers by Eleni Bairaktari Breakdown of academic impact, for papers by Margarita de la Llera-Moya Breakdown of academic impact, for papers by Gerhard M. Kostner Breakdown of academic impact, for papers by Marlys L. Koschinsky Breakdown of academic impact, for papers by Liam R. Brunham Breakdown of academic impact, for papers by G.M. Anantharamaiah
Rankless by CCL
2026